Eli Lilly files first lawsuits over retatrutide 'black market'

retatrutideNegative

AI Analysis

Summary

Eli Lilly filed its first lawsuits against six US companies for allegedly selling counterfeit or unauthorized retatrutide, an investigational diabetes and weight loss drug still in clinical trials.

Clinical Trial Data

Phase

clinical trials

Importance:5/10

Sentiment:

-0.60

litigationintellectual propertycounterfeitblack marketinvestigational drug

Related Companies

$LLY

Read the original article

Published by Endpoints News on August 12, 2026 4:38 PM

Read Original